A treat‐to‐target approach for obesity management: A post hoc analysis of the <scp>SURMOUNT</scp> ‐5 trial
In this post hoc analysis of SURMOUNT-5, most participants who reached the proposed TtT thresholds achieved the goal of low disease activity to remission defined by cardiometabolic risk parameters. These data suggest that TtT thresholds in obesity medicine may clarify goals in shared decision-making and improve clinical outcomes.
Authors
- Georgios K. Dimitriadis (ORCID: https://orcid.org/0000-0002-6662-804X)
- Beverly L. Falcón
- Çağrı Şenyücel
- Luca Busetto
- Deborah B. Horn (ORCID: https://orcid.org/0000-0003-3493-9609)
- Julia P. Dunn
- Elisa Gomez Valderas
- Luis‐Emilio Garcia‐Perez
- Theresa Hunter Gibble
- Carel W. le Roux
- Louis Aronne
Institutions
- University College Dublin (IE)
- University of Padua (IT)
- University of Ulster (GB)
- Eli Lilly (United States) (US)
- Cornell University (US)
- The University of Texas Health Science Center (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1111/dom.70531
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company